$Mainz Biomed (MYNZ.US)$Mainz Biomed Enters into Technology Partnership with EDX Medical Group 3 MINUTES AGO, 8:01 AM EDT VIA GLOBENEWSWIRE BERKELEY, Calif. and MAINZ, Germany, April 29, 2025 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) ("Mainz Biomed" or the "Company"), a molecular genetics diagnostic company specializing in the early detection of cancer, has entered into a technology partnership with UK-based EDX Medical Group plc (AQSE: EDX), which develops innovative digital diagn...
$Mainz Biomed (MYNZ.US)$ Mainz Biomed Enters into Technology Partnership with EDX Medical Group Tuesday, 29th April at 8:01 am BERKELEY, Calif. and MAINZ, Germany, April 29, 2025 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ: MYNZ) ("Mainz Biomed" or the "Company"), a molecular genetics diagnostic company specializing in the early detection of cancer, has entered into a technology partnership with UK-based EDX Medical Group plc (AQSE: EDX), which develops innovative digital diagnostic product...
$Mainz Biomed (MYNZ.US)$ Mainz Biomed Provides First Quarter 2025 Corporate Update and Path to FDA Premarket Approval Monday, 28th April at 8:01 am BERKELEY, Calif., April 28, 2025 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ: MYNZ) ("Mainz Biomed" or the "Company"), a molecular genetics diagnostic company specializing in the early detection of cancer, today reviewed its major accomplishments of the first quarter of 2025, and provided an outlook on its path to FDA premarket approval. Duri...
NOTE! 1. NFA (Not Financial Advice!) This is NOT a BUY or SELL advice. 2. Do NOT open position WITHOUT chart confirmation, indicators, momentum. 3. Scale out and secure profits. 4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability. 5. I DO NOT give buy or sell advice 6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release; FCF (free cash flow) 7. NEVER be a blind follower. ...
Space Dust
:
I wish to provide this insight as early as I can. to those selfless altruistic mooers that care enough to help others The Fallout from China’s Inflated Population Myth Background Assumption (for decades): China has 1.3–1.4 billion people. This figure became a cornerstone for trillions of dollars in global decisions: 1. Global Aid & Development Models The "Lift China out of poverty" mission was framed as humanitarian and strategic. IMF, World Bank, UN programs, and Western governments justified massive economic engagement under the belief it would help stabilize a country with a billion mouths to feed. False premise: The scale of need was misrepresented. Aid per capita may have been far more concentrated than publicly understood. --- 2. Justifying Outsourcing & Supply Chain Centralization Western companies offshored manufacturing, believing China had infinite cheap labor. The "They can't get rich—it'll all be diluted across a billion people" assumption meant little fear of China becoming a dominant competitor. Instead, the CCP aggregated the profits and built a military-tech-industrial juggernaut, unchecked. --- 3. Investment and Market Expansion Lies Corporations were told, "There are 1.4 billion customers in China!" Stock prices, R&D decisions, and global strategy pivoted on this promise. Apple, Nike, GM, Tesla, Disney, McDonald's—they all built growth models on a fantasy. In reality? The true number might be 600–800 million, and shrinking. --- 4. Debt, Infrastructure, and Global Trade Calculations The Belt and Road Initiative and Chinese creditworthiness were built on perceived demographic strength. Western banks, sovereign wealth funds, and hedge funds loaned and invested accordingly. If the population was inflated by 30–50%, then China is overbuilt, overleveraged, and underdemanded. --- 5. The Real Danger: Now, the correction begins. Empty cities = not a futuristic overbuild, but a lie laid bare. Ghost demographics mean falling internal demand, overproduction, and an existential economic crisis. The West bet on a customer base that never existed. The CCP weaponized that bet. --- Closing Line: This wasn’t just a statistical error—it was one of the most successful economic misdirections in human history. And the world economy, capital markets, and supply chains are now waking up from a 40-year dream… into a cold, shrinking reality.
來賺錢
:
Could you please clarify if a CAT fee will have to be paid for trading US stocks after May 25th? This is according to a notification from moomoo.
Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks
Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.
Mainz Biomed Stock Forum
3 MINUTES AGO, 8:01 AM EDT
VIA GLOBENEWSWIRE
BERKELEY, Calif. and MAINZ, Germany, April 29, 2025 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) ("Mainz Biomed" or the "Company"), a molecular genetics diagnostic company specializing in the early detection of cancer, has entered into a technology partnership with UK-based EDX Medical Group plc (AQSE: EDX), which develops innovative digital diagn...
Mainz Biomed Enters into Technology Partnership with EDX Medical Group
Tuesday, 29th April at 8:01 am
BERKELEY, Calif. and MAINZ, Germany, April 29, 2025 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ: MYNZ) ("Mainz Biomed" or the "Company"), a molecular genetics diagnostic company specializing in the early detection of cancer, has entered into a technology partnership with UK-based EDX Medical Group plc (AQSE: EDX), which develops innovative digital diagnostic product...
$Colombier Acquisition Corp II (CLBR.US)$ 21.44%
$Genprex (GNPX.US)$ 30.98%
$Intelligent Group (INTJ.US)$ 17.19%
$Mainz Biomed (MYNZ.US)$ 25.88%
$INVO Fertility (IVF.US)$ (NAYA) 137.07%
$Protara Therapeutics (TARA.US)$ 16.08%
$WW International (WW.US)$ 59.48%
Mainz Biomed Provides First Quarter 2025 Corporate Update and Path to FDA Premarket Approval
Monday, 28th April at 8:01 am
BERKELEY, Calif., April 28, 2025 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ: MYNZ) ("Mainz Biomed" or the "Company"), a molecular genetics diagnostic company specializing in the early detection of cancer, today reviewed its major accomplishments of the first quarter of 2025, and provided an outlook on its path to FDA premarket approval.
Duri...
1. NFA (Not Financial Advice!) This is NOT a BUY or SELL advice.
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release; FCF (free cash flow)
7. NEVER be a blind follower.
...
Mainz Biomed Achieves Double-Digit Growth: Key Partnerships Fuel Expansion in Cancer Screening
No comment yet